Literature DB >> 10868973

Genetic and physical mapping of a type 1 diabetes susceptibility gene (IDDM12) to a 100-kb phagemid artificial chromosome clone containing D2S72-CTLA4-D2S105 on chromosome 2q33.

M P Marron1, A Zeidler, L J Raffel, S E Eckenrode, J J Yang, D I Hopkins, H J Garchon, C O Jacob, M Serrano-Rios, M T Martinez Larrad, Y Park, J F Bach, J I Rotter, M C Yang, J X She.   

Abstract

Polymorphic markers within the CTLA4 gene on chromosome 2q33 have been shown to be associated with type 1 diabetes. Therefore, a gene responsible for the disease (IDDM12) most likely lies within a region of <1-2 cM of CTLA4. To define more precisely the IDDM12 interval, we genotyped a multiethnic (U.S. Caucasian, Mexican-American, French, Spanish, Korean, and Chinese) collection of 178 simplex and 350 multiplex families for 10 polymorphic markers within a genomic interval of approximately 300 kb, which contains the candidate genes CTLA4 and CD28. The order of these markers (D2S346, CD28, GGAA19E07, D2S307, D2S72, CTLA4, D2S105, and GATA52A04) was determined by sequence tagged site content mapping of bacterial artificial chromosome (BAC) and yeast artificial chromosome (YAC) clones. The transmission disequilibrium test (TDT) analyses of our data revealed significant association/linkage with three markers within CTLA4 and two immediate flanking markers (D2S72 and D2S105) on each side of CTLA4 but not with more distant markers including the candidate gene CD28. Tsp analyses revealed significant association only with the three polymorphic markers within the CTLA4 gene. The markers linked and associated with type 1 diabetes are contained within a phagemid artificial chromosome clone of 100 kb, suggesting that the IDDM12 locus is either CTLA4 or an unknown gene in very close proximity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10868973     DOI: 10.2337/diabetes.49.3.492

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  8 in total

1.  PD-1 gene haplotype is associated with the development of type 1 diabetes mellitus in Japanese children.

Authors:  Ronghua Ni; Kenji Ihara; Kenichi Miyako; Ryuichi Kuromaru; Mika Inuo; Hitoshi Kohno; Toshiro Hara
Journal:  Hum Genet       Date:  2007-01-03       Impact factor: 4.132

2.  Differential roles of costimulatory signaling pathways in type 1 diabetes mellitus.

Authors:  Bernhard O Boehm; Jeffrey A Bluestone
Journal:  Rev Diabet Stud       Date:  2005-02-10

3.  Biomarkers for type 1 diabetes.

Authors:  Sharad Purohit; Jin-Xiong She
Journal:  Int J Clin Exp Med       Date:  2008-02-29

Review 4.  Joint genetic susceptibility to type 1 diabetes and autoimmune thyroiditis: from epidemiology to mechanisms.

Authors:  Amanda Huber; Francesca Menconi; Sarah Corathers; Eric M Jacobson; Yaron Tomer
Journal:  Endocr Rev       Date:  2008-09-05       Impact factor: 19.871

Review 5.  Unravelling the genetic complexity of autoimmune thyroid disease: HLA, CTLA-4 and beyond.

Authors:  M J Simmonds; S C L Gough
Journal:  Clin Exp Immunol       Date:  2004-04       Impact factor: 4.330

6.  Lack of correlation between the levels of soluble cytotoxic T-lymphocyte associated antigen-4 (CTLA-4) and the CT-60 genotypes.

Authors:  Sharad Purohit; Robert Podolsky; Christin Collins; Weipeng Zheng; Desmond Schatz; Andy Muir; Diane Hopkins; Yi-Hua Huang; Jin-Xiong She
Journal:  J Autoimmune Dis       Date:  2005-10-31

7.  CTLA4 gene polymorphisms are associated with, and linked to, insulin-dependent diabetes mellitus in a Russian population.

Authors:  D A Chistiakov; K V Savost'anov; V V Nosikov
Journal:  BMC Genet       Date:  2001-03-27       Impact factor: 2.797

8.  Effect of CTLA-4 gene polymorphisms on long-term kidney allograft function in Han Chinese recipients.

Authors:  Yifeng Guo; Junwei Gao; Shuai Gao; Minghua Shang; Fang Guo
Journal:  Oncotarget       Date:  2016-04-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.